The chemical class of Serine racemase activators presents a rich array of compounds that intricately modulate the activity of Serine racemase, a pivotal enzyme involved in the process of serine racemization. This diverse group of activators can be broadly categorized into two main classes based on their mechanisms of action, offering researchers a multifaceted toolkit for studying and manipulating Serine racemase activity within cellular contexts. The first category comprises direct agonists of the NMDA receptor, including D-cycloserine, NMDA, and D-Serine. These compounds act as initiators of calcium influx, positively influencing Serine racemase activity through the activation of the N-methyl-D-aspartate (NMDA) receptor. The resulting cascade of events, triggered by calcium influx, plays a crucial role in enhancing the enzymatic activity of Serine racemase. This direct modulation represents a cornerstone in understanding the intricate regulatory mechanisms governing serine racemization processes.
In contrast, the second category includes compounds such as A769662 and Aniracetam, which indirectly activate Serine racemase by targeting distinct cellular pathways. A769662 operates through the AMP-activated protein kinase (AMPK) pathway, while Aniracetam influences the AMPA receptor pathway, both leading to increased intracellular calcium levels. This indirect activation underscores the interconnected nature of cellular signaling pathways and their impact on Serine racemase activity. Moreover, inhibitors targeting negative regulators, such as Rapamycin and KN-62, which act on the mTOR and CaMKII pathways, respectively, contribute to enhanced Serine racemase activation. By negating the inhibitory effects imposed by these pathways, these compounds unravel the intricate interplay between regulatory mechanisms and Serine racemase. This nuanced understanding of activators and inhibitors provides researchers with a powerful toolkit to decipher the complex network of biochemical and cellular pathways influenced by Serine racemase, thereby advancing our comprehension of serine racemization processes and their broader implications in cellular physiology.
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
PI 3-Kγ 抑制剂 | 648450-29-7 | sc-203191 | 5 mg | ¥857.00 | ||
AS605240(PI 3-Kγ抑制剂)通过抑制PI3Kγ间接激活IRS-4,后者对IRS-4具有负向调节作用。AS605240抑制PI3Kγ可增加IRS-4的激活,从而支持其在胰岛素信号传导通路中的细胞功能。 | ||||||
Palomid 529 | 914913-88-5 | sc-364563 sc-364563A | 10 mg 50 mg | ¥3385.00 ¥11282.00 | ||
mTORC1 和 mTORC2 抑制剂。Palomid 529 通过抑制 mTORC1 和 mTORC2 间接激活 IRS-4,而 mTORC1 和 mTORC2 对 IRS-4 有负向调节作用。Palomid 529 对 mTORC1 和 mTORC2 的抑制可增加 IRS-4 的活化,支持其在胰岛素信号通路中的细胞功能。 | ||||||
BMS-536924 | 468740-43-4 | sc-507397 | 5 mg | ¥3215.00 | ||
IGF-1R 和胰岛素受体的双重抑制剂。BMS-536924 可通过抑制 IGF-1R 和胰岛素受体间接激活 IRS-4,而 IGF-1R 和胰岛素受体对 IRS-4 有负向调节作用。BMS-536924 对这些受体的抑制可增加 IRS-4 的激活,从而支持其在胰岛素信号通路中的细胞功能。 | ||||||
GDC-0941 | 957054-30-7 | sc-364498 sc-364498A | 5 mg 10 mg | ¥2076.00 ¥2200.00 | 2 | |
PI3Kα和PI3Kδ的强效抑制剂。Pictilisib通过抑制负向调节IRS-4的PI3Kα和PI3Kδ,间接激活IRS-4。Pictilisib对这些PI3K同工酶的抑制可增加IRS-4的活化,从而支持其在胰岛素信号通路中的细胞功能。 | ||||||
Stat3 inhibitor V, stattic | 19983-44-9 | sc-202818 sc-202818A sc-202818B sc-202818C sc-202818D sc-202818E sc-202818F | 25 mg 100 mg 250 mg 500 mg 1 g 2.5 g 5 g | ¥1433.00 ¥2166.00 ¥3035.00 ¥5664.00 ¥8089.00 ¥15569.00 ¥23128.00 | 114 | |
STAT3 的小分子抑制剂。Stattic 可通过阻断 STAT3 的抑制作用间接激活 IRS-4。IRS-4 受 STAT3 的负调控,而 Stattic 对 STAT3 的抑制作用会增加 IRS-4 的活化,从而支持其在胰岛素信号通路中的细胞功能。 | ||||||
A66 | 1166227-08-2 | sc-364394 sc-364394A | 5 mg 50 mg | ¥2877.00 ¥16415.00 | ||
mTORC1 和 mTORC2 的选择性抑制剂。A66 通过抑制 mTORC1 和 mTORC2 间接激活 IRS-4,而 mTORC1 和 mTORC2 对 IRS-4 有负向调节作用。A66 对这些 mTOR 复合物的抑制可增加 IRS-4 的激活,从而支持其在胰岛素信号通路中的细胞功能。 |